Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03970512 · ClinicalTrials.gov registry record · NA
Apioc Toric/Spherical Single Vision Contact Lens
A NA study, sponsored by Lentechs.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT03970512: Completed NA study, sponsored by Lentechs.
NCT03970512 is a NA study that has completed, run by Lentechs. The registered enrollment target is 51 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03970512, a NA study, has completed, sponsored by Lentechs.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
The Lentechs Apioc-S and Apioc-A contact lenses are made in an FDA-approved contact lens material indicated for single-vision and astigmatism. The novel lens design has a lenticular portion which is thicker than the optical portion of the lens. When applied to the eye, it is oriented in a superior position. Unlike contact lenses currently on the market, this innovative design improves lens stability by preventing lens rotation, and may improve tear flow behind the lens.
Primary Outcome
LogMAR distance visual acuity
Interventions
- DEVICE Apioc-A and Apioc-S Contact Lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2019-05-31 |
| Est. Completion | 2021-03-18 |
| Phase | NA |
What the finished NCT03970512 record still lists
NCT03970512 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Apioc-A and Apioc-S Contact Lenses is the first listed.
NCT03970512 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03970512 about?
NCT03970512 is a clinical study titled "Apioc Toric/Spherical Single Vision Contact Lens". The Lentechs Apioc-S and Apioc-A contact lenses are made in an FDA-approved contact lens material indicated for single-vision and astigmatism. The novel lens design has a lenticular portion which is thicker than the optical portion of the lens. When applied to the eye, it is oriented in a superior p...
What is the current status of trial NCT03970512?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2019-05-31. Estimated completion is 2021-03-18.
What interventions are being tested in trial NCT03970512?
The interventions under investigation include: Apioc-A and Apioc-S Contact Lenses (DEVICE).
Who is sponsoring clinical trial NCT03970512?
This trial is sponsored by Lentechs, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03970512's enrollment target sits among peer trials
51 1279th of 2000 higher than 722 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI